Cargando…
Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
The underlying molecular mechanisms of resistance to cisplatin-based systemic chemotherapy in bladder cancer patients remain to be elucidated, while the link between androgen receptor (AR) activity and chemosensitivity in urothelial cancer has been implicated. Our DNA microarray analysis in control...
Autores principales: | Teramoto, Yuki, Jiang, Guiyang, Goto, Takuro, Mizushima, Taichi, Nagata, Yujiro, Netto, George J., Miyamoto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466436/ https://www.ncbi.nlm.nih.gov/pubmed/34576193 http://dx.doi.org/10.3390/ijms221810030 |
Ejemplares similares
-
Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
por: Jiang, Guiyang, et al.
Publicado: (2021) -
FOXO1 inactivation induces cisplatin resistance in bladder cancer
por: Ide, Hiroki, et al.
Publicado: (2020) -
ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
por: Inoue, Satoshi, et al.
Publicado: (2018) -
GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
por: Elahi Najafi, Mohammad Amin, et al.
Publicado: (2023) -
Gulp! Electronics Down the Hatch
por: Patel, Prachi
Publicado: (2017)